SLC7A1 mRNA and protein levels have been found to be higher in colorectal cancer (CRC) tissues than in normal tissues, and the application of an anti-SLC7A1 monoclonal antibody in colorectal cancer cell lines showed prominent antitumor activity [10]. The gene discussed is SLC7A1; the disease is colorectal carcinoma.